JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

JNJ

174.13

+0.25%↑

ABBV

198.84

-0.12%↓

AZN

74.32

+0.36%↑

NVS

118.56

+0.28%↑

ABT

130.85

-2.14%↓

Search

MEDNAX Inc

Открыт

СекторЗдравоохранение

14.41 1.34

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

14.02

Макс.

14.34

Ключевые показатели

By Trading Economics

Доход

-9.7M

21M

Продажи

-44M

458M

Рентабельность продаж

4.524

Сотрудники

4,120

EBITDA

-40M

9.6M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+8.16% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

31 окт. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-55M

1.1B

Предыдущая цена открытия

13.07

Предыдущая цена закрытия

14.41

Новостные настроения

By Acuity

50%

50%

162 / 374 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Very Strong Bullish Evidence

MEDNAX Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 авг. 2025 г., 17:49 UTC

Главные движущие силы рынка

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11 авг. 2025 г., 17:18 UTC

Главные движущие силы рынка

Tiziana Life Sciences Rises After FDA Approves IND for Foralumab Trial

11 авг. 2025 г., 16:25 UTC

Отчет

Correction to Constellation Software 2Q Revenue Rises, Profit Shrinks Article on Aug. 8

11 авг. 2025 г., 23:50 UTC

Обсуждения рынка

Nikkei May Rise as Yen Weakens -- Market Talk

11 авг. 2025 г., 23:42 UTC

Обсуждения рынка

Global Energy Roundup: Market Talk

11 авг. 2025 г., 23:42 UTC

Обсуждения рынка

Woodside's Share Price Implies Lofty Oil Price -- Market Talk

11 авг. 2025 г., 23:36 UTC

Обсуждения рынка

Gold Edges Higher on Likely Technical Recovery -- Market Talk

11 авг. 2025 г., 23:32 UTC

Обсуждения рынка

Argosy's New Bull Sees Sentiment Toward REITs Improving -- Market Talk

11 авг. 2025 г., 23:02 UTC

Обсуждения рынка

RBA Set to Lower OCR With New Forecasts in Focus -- Market Talk

11 авг. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

11 авг. 2025 г., 20:37 UTC

Отчет
Приобретения, слияния, поглощения

Bakkt Holdings: Andy Main Will Step Dn as Co-CEO and Director, Effective Aug 11, and Akshay Naheta Will Assume Role of CEO >BKKT

11 авг. 2025 г., 20:37 UTC

Отчет
Приобретения, слияния, поглощения

Bakkt Holdings 2Q Rev $577.9M >BKKT

11 авг. 2025 г., 20:37 UTC

Отчет
Приобретения, слияния, поглощения

Bakkt Holdings: In Upcoming Qtr, Will Conduct Comprehensive Review of Cost Structure to Ensure We Are Optimized, Driving Synergies Across Business, and Accelerating Path to Profitability >BKKT

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement: Assets 2,058 Units of Bitcoin Valued at $220.5M, 2,729 Units of Ether Valued at $6.8M, $58.1M in Cash and Cash Equivalents, USD Coin, Treasury Bills as of June 30 >EXOD

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement: Monthly Active Users 1.5M at End 2Q, Unchanged From 1.5M as of June 30, 2024 >EXOD

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement: Processed Volume $1.38B in 2Q Dn 37% From 1Q, Bitcoin, Tether (TRX Network), Tether (ETH Network), USDC, SOL Top Assets Traded in 2Q >EXOD

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement: Digital Assets and Liquid Assets $291.2M >EXOD

11 авг. 2025 г., 20:22 UTC

Отчет

Exodus Movement 2Q Rev $25.8M >EXOD

11 авг. 2025 г., 20:14 UTC

Обсуждения рынка

Canada Dollar Faces Near-Term Weakness on Trade Row, September Rate-Cut Chatter -- Market Talk

11 авг. 2025 г., 19:12 UTC

Обсуждения рынка

Crude-Oil Futures Edge Up in Rangebound Trade -- Market Talk

11 авг. 2025 г., 18:56 UTC

Обсуждения рынка

U.S. Natural-Gas Futures Fall on Forecast Loss of Late August Heat -- Market Talk

11 авг. 2025 г., 18:31 UTC

Обсуждения рынка

Mining Halt Could Lift Lithium Prices in Near Term -- Market Talk

11 авг. 2025 г., 17:43 UTC

Обсуждения рынка

Freeport-McMoRan Can Push Up Prices, Profits With Copper Tariff Protection -- Market Talk

11 авг. 2025 г., 17:28 UTC

Обсуждения рынка

Crossborder Trade Tensions Accelerate Softness in Canada Rents -- Market Talk

11 авг. 2025 г., 17:16 UTC

Обсуждения рынка

Commodity Longs Fall to 11-Month Low -- Market Talk

11 авг. 2025 г., 16:42 UTC

Приобретения, слияния, поглощения

Adobe Stock Gets a Downgrade. 'AI Is Eating Software,' Analyst Says. -- Barrons.com

11 авг. 2025 г., 16:27 UTC

Приобретения, слияния, поглощения

BBVA Says Sabadell Offer Remains in Effect

11 авг. 2025 г., 16:26 UTC

Приобретения, слияния, поглощения

BBVA Previously Said It Won't Withdraw Offer to Buy Sabadell

11 авг. 2025 г., 16:25 UTC

Приобретения, слияния, поглощения

Banco de Sabadell Announced TSB Sale on July 1

11 авг. 2025 г., 16:25 UTC

Приобретения, слияния, поглощения

Banco de Sabadell Shareholders Approved TSB Unit Sale on Aug 6

Сравнение c конкурентами

Изменение цены

MEDNAX Inc Прогноз

Целевая цена

By TipRanks

8.16% рост

Прогноз на 12 месяцев

Средняя 15.5 USD  8.16%

Максимум 16 USD

Минимум 14.5 USD

Основано на мнении 5 аналитиков Wall Street, спрогнозировавших целевые цены для MEDNAX Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

5 ratings

2

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

12.945 / 14.48Поддержка и Сопротивление

Краткосрочная

Very Strong Bullish Evidence

Среднесрочная

Neutral Evidence

Долгосрочная

Bullish Evidence

Настроения

By Acuity

162 / 374Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании MEDNAX Inc

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.